Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Rapid Therapeutic Science Laboratories, Inc. (RTSL) Return on Capital Employed (2017 - 2023)

Rapid Therapeutic Science Laboratories' Return on Capital Employed history spans 7 years, with the latest figure at 0.23% for Q2 2023.

  • For Q2 2023, Return on Capital Employed fell 66.0% year-over-year to 0.23%; the TTM value through Jun 2023 reached 0.23%, down 66.0%, while the annual FY2022 figure was 0.46%, 136.0% down from the prior year.
  • Return on Capital Employed for Q2 2023 was 0.23% at Rapid Therapeutic Science Laboratories, down from 0.25% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 4.51% in Q3 2020 and bottomed at 3.41% in Q2 2021.
  • The 5-year median for Return on Capital Employed is 0.47% (2022), against an average of 0.74%.
  • The largest annual shift saw Return on Capital Employed tumbled -430bps in 2021 before it soared 430bps in 2022.
  • A 5-year view of Return on Capital Employed shows it stood at 0.22% in 2019, then skyrocketed by 1906bps to 4.51% in 2020, then plummeted by -49bps to 2.32% in 2021, then crashed by -80bps to 0.47% in 2022, then tumbled by -51bps to 0.23% in 2023.
  • Per Business Quant, the three most recent readings for RTSL's Return on Capital Employed are 0.23% (Q2 2023), 0.25% (Q1 2023), and 0.47% (Q4 2022).